Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

7,986 public trials 713 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus

NCT00085969

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • The Whittier Institute for Diabetes La Jolla, California, United States
  • VA Medical Center San Diego, California, United States
  • MedStar Research Institute Washington D.C., District of Columbia, United States
  • Internal Medicine Associates, Department of Research Fort Myers, Florida, United States
View all 23 locations
View Trial Details
Completed

Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents

NCT00099333

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Research Site Chula Vista, California, United States
  • Research Site Butte, Montana, United States
  • Research Site Portland, Oregon, United States
  • Research Site Nashville, Tennessee, United States
View Trial Details
Completed

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin

NCT00099320

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site La Jolla, California, United States
  • Research Site San Mateo, California, United States
  • Research Site Santa Barbara, California, United States
View all 51 locations
View Trial Details
Completed

Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes

NCT00111540

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Anaheim, California, United States
  • Research Site Bellflower, California, United States
  • Research Site Burlingame, California, United States
View all 60 locations
View Trial Details
Completed

Study of Efficacy and Safety LMF237 in Patients With Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Vildagliptin Monotherapy

NCT01811485

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Novartis Investigative Site Chikushino-shi, Fukuoka, Japan
  • Novartis Investigative Site Fukuoka, Japan
  • Novartis Investigative Site Fukuoka, Japan
  • Novartis Investigative Site Iizuka, Fukuoka, Japan
View all 30 locations
View Trial Details
Completed

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes Mellitus

NCT00254254

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Research Site Little Rock, Arkansas, United States
  • Research Site San Diego, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site Louisville, Kentucky, United States
View Trial Details

Related conditions